Frontlight ResearchEarly access
Active, not recruitingNo phase
PAN-ICIS Study: ICIS for Early Detection of Infectious Complications in Pancreatic Surgery
Key facts
- Who runs it
- Charles University, Czech Republic
- Where
- Czechia1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 400 people, planned
- Started
- 1 Nov 2025
- Expected to end
- 31 Mar 2028
- Type of study
- Observational
- Record updated
- 1 December 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (6)Hide the full registry criteria
Who can take part
- Patients ≥ 18-years-old
- Indication for an elective pancreatic procedure
- Written informed consent
Who cannot take part
- Known hematologic malignancy or hematological pathology
- Patients <18 years old
- Refusal to participate
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study examines a new blood test called ICIS, which may help detect infections earlier after pancreatic surgery. Patients will have routine blood samples taken during their hospital stay, with no extra procedures required. By tracking how ICIS changes over time, investigators aim to improve early infection detection, support safer recovery, and reduce postoperative complications.
The group in the trial
- Patients following pancreatic surgery
All patients following pancreatic surgery will be enrolled in this study
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- PAN-ICIS: Prospective Observational Study Evaluating the Intensive Care Infection Score for Early Detection of Infectious Complications After Pancreatic Resections
- Record updated
- 1 December 2025